Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
60,799,281
Total 13F shares
57,251,922
Share change
+1,595,660
Total reported value
$4,197,137,135
Put/Call ratio
122%
Price per share
$73.31
Number of holders
268
Value change
+$132,883,151
Number of buys
160
Number of sells
90

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Frazier Life Sciences Management, L.P.
13F
Company
11%
6,795,121
$345,803,708 30 Jun 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
8.6%
5,236,277
$266,484,636 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
5.9%
3,577,091
$182,038,161 30 Jun 2025
13F
BVF INC/IL
13F
Company
4.5%
2,761,333
$140,524,236 30 Jun 2025
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
4.3%
2,637,485
$134,224,124 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
4.2%
2,564,869
$130,526,184 30 Jun 2025
13F
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
3%
1,495,290
$109,619,710 $0 30 Sep 2025
James E. Flynn
3/4/5
* Possible Member of 10% Group, 10%+ Owner
class O/S missing
3,244,434
$90,958,032 06 Jun 2022
Novo Holdings A/S
13F
Company
2.5%
1,500,055
$76,337,799 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.3%
1,417,215
$72,123,000 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
2.3%
1,406,352
$71,569,254 30 Jun 2025
13F
STATE STREET CORP
13F
Company
2.3%
1,375,628
$70,005,709 30 Jun 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2%
1,236,027
$62,901,414 30 Jun 2025
13F
NEA Partners 16, L.P.
3/4/5
10%+ Owner
class O/S missing
2,186,243
$61,291,541 13 Jun 2023
New Enterprise Associates 16, L.P.
3/4/5
10%+ Owner
class O/S missing
2,186,243
$61,291,541 13 Jun 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
1,029,616
$52,404,643 30 Jun 2025
13F
Clearbridge Investments, LLC
13F
Company
1.7%
1,027,527
$52,290,843 30 Jun 2025
13F
Polar Capital Holdings Plc
13F
Company
1.6%
975,000
$49,617,750 30 Jun 2025
13F
Niall O'Donnell
3/4/5
Director
class O/S missing
1,621,118
$45,448,205 11 Nov 2022
Rock Springs Capital Management LP
13F
Company
1.3%
818,206
$41,638,503 30 Jun 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
1.3%
771,146
$39,244,000 30 Jun 2025
13F
Pictet Asset Management Holding SA
13F
Company
1.2%
701,156
$35,681,829 30 Jun 2025
13F
BOONE CAPITAL MANAGEMENT LLC
13F
Company
1.1%
641,448
$32,643,289 30 Jun 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.98%
593,596
$30,208,100 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.97%
590,257
$30,038,178 30 Jun 2025
13F
Woodline Partners LP
13F
Company
0.93%
567,894
$28,900,126 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.93%
566,326
$28,820,393 30 Jun 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.91%
554,957
$28,241,762 30 Jun 2025
13F
LOOMIS SAYLES & CO L P
13F
Company
0.91%
552,957
$28,139,982 30 Jun 2025
13F
First Turn Management, LLC
13F
Company
0.87%
527,540
$26,846,511 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.82%
496,061
$25,244,557 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.79%
481,464
$24,501,703 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.79%
480,276
$24,441,244 30 Jun 2025
13F
MACQUARIE GROUP LTD
13F
Company
0.72%
435,717
$22,174,000 30 Jun 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.7%
423,744
$21,564,332 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.66%
402,396
$20,477,934 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.65%
396,348
$20,170,150 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.65%
395,008
$20,101,957 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.64%
389,270
$19,809,951 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.63%
383,160
$19,499,012 30 Jun 2025
13F
S.c.a. Candriam
13F
Individual
0.61%
373,005
$18,983,033 30 Jun 2025
13F
AXA S.A.
13F
Company
0.58%
351,682
$17,897,097 30 Jun 2025
13F
FEDERATED HERMES, INC.
13F
Company
0.57%
344,304
$17,521,630 30 Jun 2025
13F
Penn Capital Management Company, LLC
13F
Company
0.56%
342,256
$17,462,612 30 Jun 2025
13F
EMERALD ADVISERS, LLC
13F
Company
0.5%
305,766
$15,560,432 30 Jun 2025
13F
Soleus Capital Management, L.P.
13F
Company
0.49%
298,696
$15,200,639 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.47%
288,159
$14,664,412 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.43%
264,118
$13,440,964 30 Jun 2025
13F
Erste Asset Management GmbH
13F
Company
0.43%
260,000
$13,237,400 30 Jun 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.43%
258,866
$13,173,694 30 Jun 2025
13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2025

As of 30 Sep 2025, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 268 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,251,922 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc., VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, BVF INC/IL, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, NOVO HOLDINGS A/S, and TANG CAPITAL MANAGEMENT LLC. This page lists 268 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
211
Q3 2025 holders
268
Holder diff
57
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .